Abstract:Rare diseases are usually chronically debilitating or even life-threatening with diagnostic and therapeutic challenges in current clinical practice. It has been estimated that 80% of rare diseases are genetic in origin, and thus genome sequencing-based diagnosis offers a promising alternative for rare-disease management. In this study, 79 individuals from 16 independent families were performed for whole-genome sequencing (WGS) in an effort to identify the causative mutations for 16 distinct rare diseases that are largely clinically intractable. Comprehensive analysis of variations, including simple nucleotide variants (SNVs), copy-number variations (CNVs), and structural variations (SVs), was implemented using the WGS data. A flexible analysis pipeline that allowed a certain degree of misclassification of disease status was developed to facilitate the identification of causative variants. As a result, disease-causing variants were identified in 10 of the 16 investigated diseases, yielding a diagnostic rate of 62.5%. Additionally, new potentially pathogenic variants were discovered for two disorders, including IGF2/INS-IGF2 in mitochondrial disease and FBN3 in Klippel–Trenaunay–Weber syndrome. Our WGS analysis not only detected a CNV associated with 3p deletion syndrome but also captured a simple sequence repeat (SSR) variation associated with Machado–Joseph disease. To our knowledge, this is the first time the clinical WGS analysis of short-read sequences has been used successfully to identify a causative SSR variation that perfectly segregates with a repeat expansion disorder. After the WGS analysis, we confirmed the initial diagnosis for three of 10 established disorders and modified or corrected the initial diagnosis for the remaining seven disorders. In summary, clinical WGS is a powerful tool for the diagnosis of rare diseases, and its diagnostic clarity at molecular levels offers important benefits for the participating families.

A W-test collapsing method for rare variant testing with applications to exome sequencing data of hypertensive disorder

[Family-Based Association Tests for Rare Variants].

Block-based Association Tests for Rare Variants Using Kullback–Leibler Divergence

Enhancing power of rare variant association test by Zoom-Focus Algorithm (ZFA) to locate optimal testing region

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

Deviation from baseline mutation burden provides powerful and robust rare-variants association test for complex diseases

Adjustment of Familial Relatedness in Association Test for Rare Variants

CLUSTERING OF RARE VARIANTS FOR CAUSAL VARIANTS IDENTIFICATION AND EFFECT DIRECTION CLASSIFICATION

A Shrinkage Method for Testing the Hardy–Weinberg Equilibrium in Case‐Control Studies

Identification Of Sequence Variants In Genetic Disease-Causing Genes Using Targeted Next-Generation Sequencing

Kullback–Leibler Distance Methods for Detecting Disease Association with Rare Variants from Sequencing Data

Efficient variant set mixed model association tests for continuous and binary traits in large-scale whole genome sequencing studies

Fast permutation tests and related methods, for association between rare variants and binary outcomes

Pooled Association Tests for Rare Genetic Variants: A Review and Some New Results

Rare variant contribution to human disease in 281,104 UK Biobank exomes

A statistical framework for powerful multi-trait rare variant analysis in large-scale whole-genome sequencing studies

Identifying interpretable gene-biomarker associations with functionally informed kernel-based tests in 190,000 exomes

Identifying rare variants using a Bayesian regression approach

ACAT: A Fast and Powerful P-value Combination Method for Rare-variant Analysis in Sequencing Studies

Haplotype kernel association test as a powerful method to identify chromosomal regions harboring uncommon causal variants

Identification of Rare Variants for Hypertension with Incorporation of Linkage Information